|
|
|
Volumn 4, Issue 1, 1998, Pages 35-42
|
|
Prognostic markers in clinically localized prostate cancer
|
|
Author keywords
Clinically localized prostate cancer; Prognosis; Prostate cancer; Staging
|
|
Indexed keywords
KI 67 ANTIGEN;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN BCL 2;
PROTEIN P53;
ANGIOGENESIS;
APOPTOSIS;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER STAGING;
DISEASE MARKER;
HUMAN;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE ADENOCARCINOMA;
PROSTATECTOMY;
REVIEW;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADENOCARCINOMA;
APOPTOSIS;
CELL DIVISION;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
GENES, P53;
HUMANS;
MALE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0031937257
PISSN: 10793259
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (25)
|
|
References (34)
|
